News | Published:

Roche pays $1.7 billion to target tumors' genetic signatures

Nature Biotechnology volume 36, page 123 (2018) | Download Citation

Subjects

  • Subscribe to Nature Biotechnology for full access:

    $250

    Subscribe

Additional access options:

Already a subscriber?  Log in  now or  Register  for online access.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nbt0218-123

Rights and permissions

To obtain permission to re-use content from this article visit RightsLink.

Authors